⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TPST News
Tempest Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
TPST
Form 8-K
sec.gov
TPST
SKIL
Tempest Appoints John W. Frederick to Board of Directors, Strengthening Financial and Capital Markets Expertise
globenewswire.com
TPST
Form 8-K
sec.gov
TPST
Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors
globenewswire.com
TPST
Form 8-K
sec.gov
TPST
Form 8-K
sec.gov
TPST
Form 8-K
sec.gov
TPST
Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform
globenewswire.com
TPST
Tempest Therapeutics Announces Up to $7.5 Million Private Placement
globenewswire.com
TPST